Behavioral Therapy for Autism
(BTIA Trial)
Trial Summary
What is the purpose of this trial?
This trial tests a new therapy called BTIA, which helps teens with autism manage their emotions and behaviors. The therapy involves regular sessions where therapists teach both the teens and their parents how to handle frustration and improve daily functioning. The study aims to see if BTIA can reduce disruptive behaviors and help these teens function better in their everyday lives.
Will I have to stop taking my current medications?
The trial does not specify if you must stop taking your current medications, but it requires participants to be either medication-free or on stable medication. This means you should not change your current medications during the trial.
What data supports the effectiveness of the treatment Behavioral Therapy for Irritability in Autism?
Research shows that behavioral interventions, including cognitive behavioral therapy, can help reduce aggressive behavior and improve anger coping in children with autism. These treatments can decrease temper tantrums and arguing, and increase adaptive coping strategies, although they may not impact all areas of aggression and coping.12345
Is behavioral therapy for autism safe for humans?
Behavioral therapies for autism, such as those focusing on emotion regulation and challenging behaviors, have been studied extensively and are generally considered safe. These therapies often involve strategies like parent-implemented interventions, emotion regulation training, and cognitive behavioral techniques, which have shown high-quality evidence of safety in multiple studies.23467
How is Behavioral Therapy for Irritability in Autism different from other treatments for irritability in autism?
This treatment is unique because it focuses on exposure-based cognitive behavioral therapy, which helps children become more aware of their emotions and develop self-regulation skills to reduce temper tantrums and arguing. Unlike some other treatments, it emphasizes mindfulness and dialectical behavior therapy techniques to improve coping strategies, although it may not impact all areas of aggression or quality of life.12348
Research Team
Denis Sukhodolsky, Ph.D.
Principal Investigator
Yale University
Eligibility Criteria
This trial is for boys and girls aged 12-18 with autism spectrum disorder who live near New Haven, CT. They should have disruptive behaviors like irritability or anger outbursts but no severe psychiatric disorders needing immediate treatment. Participants can be medication-free or on a stable regimen without planned changes.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Behavioral Therapy for Irritability and Aggression (BTIA) or Psychoeducation and Supportive Therapy (PST) in 15 weekly, ninety-minute sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Behavioral Therapy for Irritability in Autism (Behavioral Intervention)
- Psychoeducation and Supportive Therapy (PST) (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
Nancy J. Brown
Yale University
Chief Medical Officer since 2020
MD from Yale School of Medicine
Peter Salovey
Yale University
Chief Executive Officer since 2013
PhD in Psychology from Yale University
Congressionally Directed Medical Research Programs
Collaborator
Colonel Mark G. Hartell
Congressionally Directed Medical Research Programs
Director, Congressionally Directed Medical Research Programs since 2022
PhD in Analytical Chemistry from Auburn University, MS in Biophysical Chemistry from Ohio State University, BS in Chemistry from State University of New York at Oswego
Dr. Sarah Goldman
Congressionally Directed Medical Research Programs
Chief Medical Officer since 2023
MD